Executive Director, Stanford Laboratory for Cell and Gene Medicine

Executive Director, Stanford Laboratory for Cell and Gene Medicine

Stanford University

Stanford, CA, United States

Executive Director, Stanford Laboratory for Cell and Gene Medicine

Stanford University School of Medicine seeks to hire an Executive Director for the Stanford Laboratory for Cell and Gene Medicine (LCGM). Candidates must hold a Ph.D., M.D. or M.D/Ph.D. The appointment will be in the Clinician Educator Line, with rank based on years of relevant experience. The major criterion for appointment for Clinician Educators is excellence in the overall mix of clinical care and clinical teaching appropriate to programmatic need. We encourage Clinician Educators to participate in research projects of interest, as their clinical and educational responsibilities permit.

The Executive Director, in consultation with the Executive Committee, manages and leads the activities of the LCGM by developing and implementing policies, procedures, and program priorities consistent with those established by Stanford Health Care, Stanford Children’s Health, and the Stanford University School of Medicine and determining the most effective use of resources to carry out goals and objectives.

The LCGM is a 25,000-square-foot facility opened in 2016 and was created to expand cell and gene therapy clinical materials production capabilities for Stanford Medicine. This recent building renovation, which includes quality control laboratories, allows for process development, manufacturing, testing, and storage of cell and viral vector products primarily for Phase I/II clinical investigations in accordance with the Food and Drug Administration’s current good manufacturing practices (cGMP) as described in the Code of Federal Regulations (CFR) Title 21 (parts 210, 211). The LCGM functions independently from—but in collaboration with—the Blood and Marrow Transplantation/Cell Therapy Facility, which is operated within Stanford Health Care. Currently employing 40 staff across functional groups—Process Development & Manufacturing, Quality Assurance, Quality Control, Operations, Regulatory Affairs, Finance and Administration—LCGM serves 8 Stanford Investigators across diverse clinical specialties and departments including adult and pediatric genome editing and stem cell transplantation, dermal skin grafts for epidermolysis bulosa, CAR-T therapy, antigen specific regulatory T-cells and cancer immunotherapy with multiple additional projects in queue for iPSC-derived smooth muscle cells for treating urinary incontinence; and cellular therapies for cornea endothelial dysfunction, stroke and recurring ovarian cancer.
Candidates should submit a cover letter of interest and curriculum vitae in one pdf document to:

Thomas J. Montine, MD, PhD
Chair, Department of Pathology
c/o Cynthia Llanes
via email to cllanes@stanford.edu

Stanford is an equal employment opportunity and affirmative action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, protected veteran status, or any other characteristic protected by law. Stanford also welcomes applications from others who would bring additional dimensions to the University’s research, teaching and clinical missions.


Apply with CV and Cover Letter

Fields with a * are mandatory
Must be a .doc, .docx, or .pdf file and no larger than 1MBMust be a .doc, .docx, or .pdf file and no larger than 1MB

Executive Director, Stanford Laboratory for Cell and Gene Medicine